Clinical Trial Update: Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating epirubicin-based interventional chemotherapy for sinonasal adenoid cystic carcinoma (SNACC) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Sinonasal Carcinoma

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Adenoid Cystic Carcinoma, Sinonasal Carcinoma | Phase 2 | Status: RECRUITING